PDF herunterladen
Thromb Haemost 1982; 48(01): 059-061
DOI: 10.1055/s-0038-1657216
Original Article
Schattauer GmbH Stuttgart

Catabolism of Purified Rat Fibrin(ogen) Plasmin Degradation Products in Rats

W Nieuwenhuizen
The Gaubius Institute, Health Research Division TNO, Leiden, The Netherlands
,
J J Emeis
The Gaubius Institute, Health Research Division TNO, Leiden, The Netherlands
,
A Vermond
The Gaubius Institute, Health Research Division TNO, Leiden, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 17. März 1982

Accepted 18. Mai 1982

Publikationsdatum:
13. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

The blood clearance of purified plasmin degradation products (X, Y, D-dimer, Dcate, D EGTA, E-fibrin, Ecate and E EGTA) of rat fibrin(ogen) has been studied in a homologous system. Transcapillary flux rate constants, fractional catabolic rate constants and the ratios of intravascular and extravascular pools have been calculated. There are considerable differences in these constants between the two early fibrinogen degradation products X and Y. Also the differences between fibrinogen D and E fragments, derived from different parts of the fibrinogen molecule, are considerable. However, the differences between fibrin fragment D-dimer and fibrinogen fragment Dcate are relatively small. Also the differences between fragments E-fibrin, Ecate and EEGTA are small. The main fraction of all E-fragments is extravascular.

Keywords

Catabolism in vivo - Rat fibrin(ogen) degradation products - Rat model
 

  • References

  • 1 Latallo ZS, Budzynski AZ, Lipinski B, Kowalski E. Inhibition of thrombin and fibrin polymerization. Two activities derived from plasmin digested fibrinogen. Nature 1964; 203: 1184-1185
    CrossrefPubMedGoogle Scholar
  • 2 Larrieu MJ, Dray L, Ardaillou N. Biological effects of fibrinogenfibrin degradation products. Thrombos Diathes Haemorrh 1975; 34: 686-692
    PubMedGoogle Scholar
  • 3 Haverkate F, Timan G, Nieuwenhuizen W. Anticlotting properties of fragments D from human fibrinogen and fibrin. Eur J Clin Invest 1979; 9: 253-255
    CrossrefPubMedGoogle Scholar
  • 4 Nieuwenhuizen W, Gravesen M. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen produced by plasmin (fragments X). Biochim Biophys Acta 1981; 688: 81-88
    PubMedGoogle Scholar
  • 5 Kessler CM, Bell WR. Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products. Blood 1980; 55: 40-47
    PubMedGoogle Scholar
  • 6 Itteryerah TR, Weidner N, Wochner RD, Sherman LA. Effect of fibrin degradation products and thrombin or fibrinogen synthesis. Br J Haematol 1979; 43: 661-668
    CrossrefPubMedGoogle Scholar
  • 7 Kessler CM, Bell WR. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits. J Lab Clin Med 1979; 93: 768-782
    PubMedGoogle Scholar
  • 8 Franks JJ, Kirsch RE, Frith LOC, Purves LR, Franks WT, Franks JA, Mason P, Saunders SJ. Effect of fibrinogenolytic products D and E on fibrinogen and albumin synthesis in the rat. J Clin Invest 1981; 67: 575-580
    CrossrefPubMedGoogle Scholar
  • 9 Doolittle RF. Structural aspects of the fibrinogen to fibrin conversion. Adv Prot Chem 1973; 27: 100-109
    PubMedGoogle Scholar
  • 10 Marder VJ, Budzynski AZ. The structure of the fibrinogen degradation products. Progr Hemostasis Thromb 1974; 2: 141-174
    PubMedGoogle Scholar
  • 11 Haverkate F, Timan G. Protective effect of calcium in the plasmic degradation of fibrinogen and fibrin fragments D. Thromb Res 1977; 10: 803-812
    CrossrefPubMedGoogle Scholar
  • 12 Van Ruijven-Vermeer IAM, Nieuwenhuizen W, Haverkate F, Timan G. A novel method for the rapid purification of human and rat fibrin(ogen) degradation products in high yields. Hoppe-Seyler's Z physiol Chem 1979; 360: 633-637
    PubMedGoogle Scholar
  • 13 Graeff HR, Hafter R, Bachman L. Subunit and macromolecular structure of circulating fibrin from obstetrical patients with intravascular coagulation. Thromb Res 1979; 16: 313-328
    CrossrefPubMedGoogle Scholar
  • 14 Gaffney PJ, Lane DA, Kakkar VV, Brasher M. Characterization of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res 1975; 7: 89-99
    CrossrefPubMedGoogle Scholar
  • 15 Graeff HR, Hafter R. Detection and relevance of crosslinked fibrin derivatives in blood. Semin Thromb Haemostas 1982; 8: 57-68
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Larrieu MJ, Ardaillou M, Attali-Dray L. The catabolism of human fibrinogen and fibrinogen degradation products. In: Fibrinolysis, current fundamental and clinical concepts. Gaffney PJ. Balkuv-Ulutin. (Eds), Academic Press; New York: 1978: 137-146
    Google Scholar
  • 17 Sherman LA. Catabolism of fibrinogen and its derivatives. Thromb Haemostas 1977; 38: 809-822
    PubMedGoogle Scholar
  • 18 Hayne OA, Sherman LA. In vivo behaviour of fibrinogen fragment D in experimental renal hepatic and reticuloendothelial dysfunction. Am J Pathol 1973; 71: 219-237
    PubMedGoogle Scholar
  • 19 Catanzaro A, Hathaway G, Strathem J, Edgington T. Structure and in vivo behaviour of human fibrinogen fragment D. Proc Exptl Biol Med 1972; 139: 1401-1406
    PubMedGoogle Scholar
  • 20 Catanzaro A, Edgington T. The in vivo behaviour of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin. J Lab Clin Med 1974; 83: 458-466
    PubMedGoogle Scholar
  • 21 Ardaillou N, Dray L, Budzynski AZ, Marder VJ, Larrieu MJ. The half-life of plasmic degradation products of human fibrinogen in rabbits. Thromb Haemostas 1977; 37: 201-209
    PubMedGoogle Scholar
  • 22 Chang ML, Bang NU. Biological behaviour of higher molecular weight products of fibrinolysis. J Lab Clin Med 1977; 90: 216-226
    PubMedGoogle Scholar
  • 23 Iio A, Rutherford WE, Wochner RD, Spilberg I, Sherman LA. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradation fragments D and E. J Lab Clin Med 1976; 87: 934-946
    PubMedGoogle Scholar
  • 24 Nieuwenhuizen W, Emeis JJ, Vermond A, Kurver P, Van der Heide D. Studies on the catabolism and distribution of fibrinogen in rats. Application of the Iodogen® labelling technique. Biochem Biophys Res Commun 1980; 97: 49-55
    CrossrefPubMedGoogle Scholar
  • 25 Nieuwenhuizen W, Emeis JJ, Vermond A. Comparison of the in vivo clearance of des-AA and des-AABB rat fibrin monomers prepared by different methods. Biochem Biophys Res Commun 1982; 105: 1122-1127
    CrossrefPubMedGoogle Scholar
  • 26 Emeis JJ, Lindeman J, Nieuwenhuizen W. Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol 1981; 103: 337-344
    PubMedGoogle Scholar
  • 27 Respiration and Circulation. Volume of blood in tissue: vertebrates. Altman PL, Dittmer PS. (Eds). Chapter 148: 386 Fed Am Soc Exptl Biol; Bethesda: 1971
    Google Scholar
  • 28 Atencio AC, Bailey MR, Reeve EB. Studies on the metabolism and distribution of fibrinogen in young and older rabbits. I. Methods and models. J Lab Clin Med 1965; 66: 1-19
    PubMedGoogle Scholar
  • 29 Collen D, Tytgat GN, Claeys H, Piessens R. Metabolism and distribution of fibrinogen turnover in physiological conditions in human. Br J Haematol 1972; 22: 681-700
    CrossrefPubMedGoogle Scholar
  • 30 Van Ruijven-Vermeer IAM, Nieuwenhuizen W, Nooijen WJ. Cabinding of rat fibrinogen and fibrin(ogen) degradation products. FEBS Letters 1978; 93: 177-180
    CrossrefPubMedGoogle Scholar
  • 31 Van der Drift ACM, Poppema A, Haverkate F, Nieuwenhuizen W. Hydrodynamic characterization of plasmin degradation products from human fibrinogen. To be published in: Fibrinogen, Recent Biochemical and Medical Aspects. Henschen A, Graeff H, Lottspeich F. (Eds). Walter de Gruyter; Berlin: 1981
    Google Scholar
  • 32 Lindsey GG, Brown G, Merrifield EH, Purves LR. The carbohydrate prosthetic groups of rat fibrinogen plasmic fragment E. Biochim Biophys Acta 1979; 577: 110-116
    CrossrefPubMedGoogle Scholar